Skip to main content
SpringerLink
Log in

Asymptomatische konzentrische Gesichtsfelddefekte und Optikusatrophie

  • Bild und Fall
  • Published:
Der Ophthalmologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Eke T, Talbot JF, Lawden MC (1997) Severe persistent visual field constriction associated with vigabatrin. BMJ 314:180–181

    PubMed  Google Scholar 

  2. Harding GF (1997) Severe persistent visual field constriction associated with vigabatrin. Four possible explanations exist. BMJ 314:1694

    Google Scholar 

  3. Hardus P, Verduin WM, Berendschot TT, Kamermans M, Postma G, Stilma JS, van Veelen CW (2001) The value of electrophysiology results in patients with epilepsy and vigabatrin associated visual field loss. Acta Ophthalmol Scand 79:169–174

    Article  PubMed  Google Scholar 

  4. Hardus P, Verduin WM, Engelsman M, Edelbroek PM, Segers JP, Berendschot TT, Stilma JS (2001) Visual field loss associated with vigabatrin: quantification and relation to dosage. Epilepsia 42:262–267

    Article  PubMed  Google Scholar 

  5. Hardus P, Verduin W, Berendschot T, Postma G, Stilma J, van Veelen C (2003) Vigabatrin: longterm follow-up of electrophysiology and visual field examinations. Acta Ophthalmol Scand 81:459–465

    Article  PubMed  Google Scholar 

  6. Johnson MA, Krauss GL, Miller NR, Medura M, Paul SR (2000) Visual function loss from vigabatrin: effect of stopping the drug. Neurology 55:40–45

    Google Scholar 

  7. Lawden MC, Eke T, Degg C, Harding GF, Wild JM (1999) Visual field defects associated with vigabatrin therapy. J Neurol Neurosurg Psychiatry 67:716–722

    PubMed  Google Scholar 

  8. Malmgren K, Ben-Menachem E, Frisen L (2001) Vigabatrin visual toxicity: evolution and dose dependence. Epilepsia 42:609–615

    Article  PubMed  Google Scholar 

  9. Nousiainen I, Mantyjarvi M, Kalviainen R (2001) No reversion in vigabatrin-associated visual field defects. Neurology 57:1916–1917

    PubMed  Google Scholar 

  10. Viestenz A, Viestenz A, Mardin CY (2003) Vigabatrin-associated bilateral simple optic nerve atrophy with visual field constriction. A case report and a survey of the literature. Ophthalmologe 100:402–405

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt:

Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.

Author information

Authors and Affiliations

  1. Klinik für Augenheilkunde, Philipps-Universität, Marburg

    S. Mennel, S. Schulze & C. H. Meyer

  2. Klinik für Augenheilkunde, Philipps-Universität, Robert-Koch-Straße 4, 35037 , Marburg

    S. Mennel

Authors
  1. S. Mennel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Schulze
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. H. Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Mennel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mennel, S., Schulze, S. & Meyer, C.H. Asymptomatische konzentrische Gesichtsfelddefekte und Optikusatrophie. Ophthalmologe 103, 530–532 (2006). https://doi.org/10.1007/s00347-005-1263-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00347-005-1263-x

Search

Navigation